Catalyst Wire Dossier Catalyst Wire Dossier

AMT-011

lipoprotein lipase gene therapy vector expressing human LPL S447X · Amsterdam Molecular Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMT-011, covering 2011-09-30 to 2011-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X] [Phase 2, Phase 3]

See pricing